✦ LIBER ✦
353 Oral Phase III multicenter randomized study of concurrent twice-a-day continuous radiotherapy with and without Cisplatin-5FU chemotherapy (BiRCF) in locally advanced unresectable pharyngeal squamous-cell carcinoma. Preliminary results regarding feasibility, early tolerance and control at 6 months (FNCLCC-GORTEC)
- Book ID
- 119513004
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 137 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0167-8140
No coin nor oath required. For personal study only.